Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry-Reference-Cited by-同舟云学术

Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry

Published:2022-08-24 Issue:10 Volume:97 Page:1337-1347
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Rosenbloom Barry E.¹^ORCID,Cappellini Maria Domenica²³^ORCID,Weinreb Neal J.⁴⁵,Dragosky Marta⁶,Revel‐Vilk Shoshana⁷⁸^ORCID,Batista Julie L.⁹,Sekulic Davorka¹⁰,Mistry Pramod K.¹¹^ORCID

Affiliation:

1. Department of Medicine Cedars‐Sinai Medical Center Los Angeles California USA

2. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano Milan Italy

3. Department of Internal Medicine University of Milan Milan Italy

4. Division of Hematology, Department of Internal Medicine University of Miami Miller School of Medicine Miami Florida USA

5. Division of Clinical Genetics, Department of Human Genetics University of Miami Miller School of Medicine Miami Florida USA

6. Department of Hematology Henry Moore Institute Buenos Aires Argentina

7. Department of Pediatric Hematology, School of Medicine Hebrew University Jerusalem Israel

8. Gaucher Unit, Shaare Zedek Medical Center Jerusalem Israel

9. Department of Epidemiology and Biostatistics Sanofi Cambridge Massachusetts USA

10. Global Medical Affairs Hematology, Sanofi, Cambridge Massachusetts USA

11. Department of Internal Medicine Yale University School of Medicine New Haven Connecticut USA

Funder

Sanofi

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26675

Reference63 articles.

1. ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature

2. Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism

3. Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance

4. Gaucher Disease and Malignancy: A Model for Cancer Pathogenesis in an Inborn Error of Metabolism

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploratory survey study on adjunctive use of medical cannabis for Gaucher disease;Rare Disease and Orphan Drugs Journal;2024-08-23

2. Regression of smoldering myeloma with treatment of Gaucher disease;Blood Advances;2024-03-27

3. What should rheumatologists know about Gaucher disease and Fabry disease? Connecting the dots for an overview;Advances in Rheumatology;2024-03-22

4. A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach;International Journal of Biological Sciences;2024

5. Cancer Risk in Patients with Gaucher Disease Using Real-World Data;Journal of Clinical Medicine;2023-12-15